Local treatment during angioplasty;Traitement local lors de l'angioplastie

Archives des Maladies du Coeur et des Vaisseaux

Volumn 92, Issue 11 SUPPL., 1999, Pages 1699-1706

  Brasselet, C ^a   Addad, F ^b   Lemarchand, P ^b   Lafont, A ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMECHANICS; CORONARY ARTERY OBSTRUCTION; HUMAN; RESTENOSIS; SCAR FORMATION; TISSUE REPAIR; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRACHYTHERAPY; CORONARY DISEASE; CORONARY THROMBOSIS; HUMANS; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STENTS; VENTRICULAR REMODELING;

EID: 0032729703     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lafont A, Whitlow P, Cornhill JF, Chisolm G. Restenosis after experimental angioplasly: intimal, medial and adventitial changes associated with constrictive remodelling. Circ Res 1995 ; 76 : 996-1002.
2. Lafont A, Moreyra C, Grati Z et al. Élargissement compensateur versus constriction chronique. Les 2 modalités du remodelage vasculaire après angioplastie expérimentale. Arch Mal Cœur 1997 ; 90 : 827-34.
3. Bonan R, Palement D, Scortichini MJ et al. In situ administration of anti transforming growth factor b antibodies and prevention of coronary restenosis in a swine model (abstract). Eur Heart J 1994 ; 15 : 560.
4. Fram DB, Aretz TA, Milchel JF, Azrin MA, Gillian LP, Mc Kay RG. Localised intramural delivery of heparin during balloon angioplasty: a new technique using heparin coated balloons and active diffusion (abstract). J Am Coll Cardiol 1993 ; 21 : 118A.
5. Azrin MA, Mitchel JF, Pedersen C et al. Inhibition of smooth muscle cell proliferation in vivo following local delivery of antisenses oligonucleotides to c-myb during angioplasty (abstract). J Am Coll Cardiol 1994 ; 1A-484A : 396A.
6. Mitchel JF, Azrin MA, Fram DB et al. Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons. Circulation 1994 ; 90 : 1979-88.
7. Steg PG, Feldman L, Scoazec JY et al. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation 1994 ; 90 : 1648-56.
8. Steg PG, Tahlil O, Aubailly N et al. Reduction of restenosis after angioplasty in a atheromatous rabbit model by suicide gene therapy. Circulation 1997 ; 96 : 408-11.
9. Mitchel JF, Fram DB, Palme DF et al. Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. Circulation 1995 ; 91 : 785-93.
10. Glazier JJ, Kiernan FJ, Bauer HH et al. Treatment of thrombotic saphenous vein bypass grafts using local urokinase infusion therapy with the dispatch catheter. Cathet Cardiovasc Diagn 1997 ; 41 : 261-7.
11. Oberhoff M, Novak S, Herdeg C et al. Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty. Cardiovasc Res 1998 ; 38 : 751-62.
12. Baumbach A, Oberhoff M, Rübsawen K et al. Porous balloon delivery of low molecular weight heparin in the dog coronary artery. Eur Heart J 1996 ; 17 : 1538-45.
13. Lambert CR, Leone JE, Rowland LM. Local drug delivery catheters : functional comparison of porous and micro porous designs. Cor Art Dis 1993 ; 4 : 469-75.
14. Hong MK, Chiu Wong SC, Barry JJ, Bramwell O, Tjurmin A, Leon MB. Feasibility and efficacy of locally delivered enoxoparin via the channeled balloon catheter on smooth muscle cell proliferation following balloon injury in rabbits. Cathet Cardiovasc Diagn 1997 ; 41 : 241-5.
15. Mitchel JF, Barry JJ, Bow L, Alberghini TA, Abbas SA, Mc Kay RG. Local urokinase delivery with the channel balloon. Cathet Cardiovasc Diagn 1997 ; 41 : 254-60.
16. Feldman L, Steg PG, Zheng Lu P et al. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in atherosclerotic rabbit. J Clin Invest 1995 ; 95 : 2662-71.
17. Gunn J, Holt CM, Shepherd L, Francis SE, Smith GH, Gumberland DC. Local delivery of C-myb antisense attenuates neointimal thickening in a porcine model of coronary angioplasty. J Am Coll Cardio 1995 ; 25 (suppl. 1) : 376 A.
18. Fernandez-Otiz A, Meyer BJ, Maihlac A et al. A new approach for local intravascular drug delivery. Circulation 1994 ; 89 : 1518-22.
19. Mitchel JF, Azrin MA, Fram DB, Bow LM, Mc Kay RG. Localized delivery of heparin to angioplasty sites with iotophoresis. Cathet Cardiovasc Diag 1997 ; 41 : 315-23.
20. Pavlides GS, Barath P, Maginas A, Varilikos V, Colkinos DV, O'Neill W. Intramural drug delivery by direct injection within the arterial wall : first clinical experience with a novel intra coronary delivery infiltrator system. Cathet Cardiovasc Diag 1997 ; 41 : 287-92.
21. Barath P, Popov A, Dillehay GC et al. Infiltrator angioplasty balloon catheter : a device for combined angioplasty and intramural site specific treatment. Cathet Cardiovasc Diag 1997 ; 41 : 333-41.
22. Varenne O, Pislaru S, Gillijns H et al. Local adenovirus mediated transfert of human endothelial nitric oxide synthase reduce luminal narrowing after coronary angioplasty in pigs. Circulation 1998 ; 95 : 919-26.
23. Lafont A, Guerot C, Lemarchand P. Witch gene for witch restenosis? Lancet 1995 ; 346 : 1442-3.
24. Lafont A, Danel C, Guerot C, Desnos P, Lemarchand P. Gene therapy in restenosis after angioplasty: in vivo gene transfer and expression in rabbit atherosclerotic arteries using replication deficient adenovirus vectors. Eur J Cardiol 1995 ; 16 : 27.
25. Dev V, Eigler N, Fishbein MC et al. Sustained local drug delivery to the arterial wall via biodegradable microspheres. Cath Cardiovasc Diagn 1997 ; 41 : 324-32.
26. Guzman LA, Labhasetwar V, Song C et al. Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation 1996 ; 94 : 1441-8.
27. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994 ; 23 : 1491-8.
28. Condado JA, Waksman R, Gurdiel O et al. Long term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intra coronary radiation therapy in humans. Circulation 1997 ; 96 : 727-32.
29. Terstein PS, Massullo V, Jani S et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997 ; 336 : 1697-703.
30. Verin V, Urban P, Popowski Y et al. Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study. Circulation 1997 ; 95 : 1138-44.
31. King SB, Williams DO, Chougule P et al. Endovascular beta-radiation to reduce restenosis after balloon angioplasty: results of the Beta Energy Restenosis Trial. Circulation 1997 ; 97 : 2025-30.
32. Teirstein PS, Massullo V, Jani S et al. Catheter-based radiotherapy to inhibit coronary restenosis after coronary stenting. N Engl J Med 1997 ; 336 : 1697-703.
33. Waksman R, White RL, Chan RC et al. Intracoronary radiation therapy for patients with in-stent restenosis: 6 month follow-up of a randomized clinical study. Circulation 1998 ; 98 : 17. 1-651 : 3421.
34. Leon MB, Teirstein PS, Lansky AL et al. Intracoronary gamma radiation to reduce in-stent restenosis: the multicenter Gamma I randomized clinical trial (abstract). J Am Coll Cardiol 1999 ; 33 : 56A.
35. Faxon DP, Buchbinder M, Cleman MW et al. Intracoronary radiation to prevent restenosis in native coronary lesions: the results of the pilot phase of the ARREST trial (abstract). J Am Coll Cardiol 1999 ; 33 : 19A.
36. Waksman R, Porrazzo MS, Chan RC et al. Results from the ARTISTIC feasibility study of 192-iridium gamma radiation to prevent recurrence of in-stent restenosis. Circulation 1998 ; 98 (17), 1-442 : 2327.
37. King SB, Williams DO, Chougule P et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty. Results of the beta energy restenosis trial (BERT) (abstract). Circulation 1998 ; 97 : 2025-30.
38. Weinberger J. Clinical experience with the liquid-filled balloon: the CURE study (abstract). Advances in Cardiovascular Radiation therapy III, Washington DC, Feb. 17-19, 1999.
39. Strecker EP, Gabelmann A, Boos I et al. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc Interventional Radiol 1998 ; 21 : 487-96.
40. De Scheerder I, Wang K, Wilczek K et al. Experimental study of thrombogenicity and foreign body reaction induced by heparin coated coronary stents. Circulation 1997 ; 95 : 1549-53.
41. Investigators. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT II). Lancet 1998 ; 352 : 673-81.
42. th local drug delivery meeting and cardiovascular course on radiation and molecular strategies. Suisse : Genève.
43. Heublin B, Ozbeck C, Pethig K. Silicon Carbide coated stents: clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg 1998 ; 5 : 32-6.
44. Ozbeck C, Heisel A, Gross B, Bay W, Schieffer H. Coronary implantation of Silicon Carbide coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation. Cath Cardiovasc Diag 1997 ; 41 : 71-8.
45. Dzaviik V, Carere RG, Teo KK, Kundtson ML, Marquis JF, Buller CE. Total Occlusion Study of Canada Investigators. Canadian J Cardiol 1998 ; 14 : 825-32.
46. Steg PG, Feldman L. Gene therapy of restenosis. Pathol Biol 1998 ; 46 : 201-4.